Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease.

"Declarations Conflict of interestHans H. Herfarth has served as a consultant for Alivio, AMAG, BMS, Boehringer, ExeGI, Finch, Fresenius Kabi, Galapagos, Janssen, Gilead, Lycera, Merck, Otsuka, Pfizer, PureTech, Seres, Ventyx and research support from Artizan Biosciences, Allakos, NovoNordisk, and Pfizer. Millie D. Long has served as a consultant for AbbVie, Takeda, Janssen, Pfizer, Lilly, Prometheus, Target Real World Evidence and has received research support from Pfizer, Takeda and Lilly. Edward L. Barnes has served as a consultant for AbbVie, Eli Lilly, Bristol-Meyers Squibb, and Target RWE. Kimberly Darlington, Animesh Jain, Priyanka Vedak and Paul Googe have no relevant disclosures for this work. Conflict of interest Hans H. Herfarth has served as a consultant for Alivio, AMAG, BMS, Boehringer, ExeGI, Finch, Fresenius Kabi, Galapagos, Janssen, Gilead, Lycera, Merck, Otsuka, Pfizer, PureTech, Seres, Ventyx and research support from Artizan Biosciences, Allakos, NovoNordisk, and Pfizer. Millie D. Long has served as a consultant for AbbVie, Takeda, Janssen, Pfizer, Lilly, Prometheus, Target Real World Evidence and has received research support from Pfizer, Takeda and Lilly. Edward L. Barnes has served as a consultant for AbbVie, Eli Lilly, Bristol-Meyers Squibb, and Target RWE. Kimberly Darlington, Animesh Jain, Priyanka Vedak and Paul Googe have no relevant disclosures for this work."

"Funding This research was supported by Grants from the National Institutes of Health [K23DK127157-01 ELB]."